familial Mediterranean fever

Search with Google Search with Bing
Information
Disease name
familial Mediterranean fever
Disease ID
DOID:2987
Description
"An autoimmune disease characterized by recurrent episodes of fever and acute inflammation of the membranes lining the abdomen, joints and lungs; that has_material_basis_in mutations in the MEFV gene, which encodes the protein pyrin." [url:http\://en.wikipedia.org/wiki/Familial_Mediterranean_fever, url:https\://www.rarediseases.org/rare-disease-information/rare-diseases/byID/127/viewAbstract]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT06257342 Active, not recruiting Physical Abilities of Teenagers With Familial Mediterranean Fever July 30, 2023 December 31, 2027
NCT00094900 Completed Phase 2 Interleukin-1 Trap to Treat Autoinflammatory Diseases October 2004 December 2010
NCT00582907 Completed Phase 2 Rilonacept for Treatment of Familial Mediterranean Fever (FMF) August 2008 September 2011
NCT05177120 Completed Central Sensitization in Familial Mediterranean Fever (FMF) June 1, 2021 August 3, 2022
NCT03747315 Completed A Diagnostic Test for Familial Mediterranean Fever December 15, 2018 December 15, 2020
NCT04729218 Completed The Movement Imagery Ability in Patients With Familial Mediterranean Fever January 1, 2018 February 18, 2021
NCT01075906 Completed Phase 1 Pharmacokinetics Study of Colchicine in Familial Mediterranean Fever (FMF) Patients August 2010 December 2011
NCT01088880 Completed Phase 2 Efficacy and Safety of Canakinumab in Patients With Colchicine Resistant Familial Mediterranean Fever April 2010 August 2011
NCT01705756 Completed Phase 3 Kineret (Anakinra), in Adult Patients With Colchicine-Resistant Familial Mediterranean Fever November 2012 June 2015
NCT02602028 Completed Phase 4 The Comparison of the Efficacy of Once and Twice Daily Colchicine Dosage in Pediatric Patients With FMF April 2011 August 2013
NCT03446209 Completed Phase 2 Tocilizumab for the Treatment of Familial Mediterranean Fever April 23, 2018 October 30, 2020
NCT06033339 Not yet recruiting N/A Assessment of microRNAs Role in Familial Mediterranean Fever FMF Pathophysiology October 2, 2023 October 2, 2025
NCT05488561 Not yet recruiting N/A Clinical and Molecular Evaluation of Childern With Familial Meditterranean Fever and Their Siblings August 15, 2022 August 2023
NCT06338891 Recruiting Can Gluten/Wheat or Other Foods be Responsible for FMF Attacks May 1, 2024 May 1, 2025
NCT05092776 Recruiting Phase 2 Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine April 29, 2021 October 2024
NCT05190991 Recruiting Phase 2 Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean Fever October 5, 2021 August 2026
NCT05596643 Recruiting Investigation of Autonomic Dysfunction in Patients With Familial Mediterranean Fever March 15, 2022 October 31, 2022
NCT06034795 Recruiting Evaluation of Bone Metabolism in Children and Adolescents With Familial Mediterranean Fever January 8, 2022 January 2025
NCT01059279 Terminated Heat Intolerance in the Group of FMF Patients December 2009 March 3, 2024
NCT02175589 Unknown status Phase 2 Controlled Ceasing of Colchicine Therapy in Familial Mediterranean Fever (FMF) Patients With Single MEFV (Mediterranean Fever) Gene Mutation June 2014 January 2015
NCT00658060 Unknown status Magnetic Resonance (MR) Spectroscopy In Familial Mediterranean Fever (FMF) Patients September 2007
NCT04724993 Unknown status N/A Effects of Online Aerobic Exercise Training and Physical Activity Counseling in Juvenile Familial Mediterranean Fever December 20, 2020 December 2021
NCT04478409 Unknown status Characterization of a Functional Test for Mediterranean Family Fever Screening - 2 July 21, 2021 June 2024
NCT00323440 Withdrawn Inflammatory Proteins in Familial Mediterranean Fever During Attack and Remission August 2008 August 2016
NCT05448391 Withdrawn Phase 2 A Study to Evaluate RIST4721 in Familial Mediterranean Fever (FMF) September 13, 2022 December 30, 2024
Disase is a (Disease Ontology)
DOID:417
Cross Reference ID (Disease Ontology)
GARD:6421
Cross Reference ID (Disease Ontology)
ICD10CM:M04.1
Cross Reference ID (Disease Ontology)
ICD9CM:277.31
Cross Reference ID (Disease Ontology)
MESH:D010505
Cross Reference ID (Disease Ontology)
MIM:134610
Cross Reference ID (Disease Ontology)
MIM:249100
Cross Reference ID (Disease Ontology)
NCI:C84707
Cross Reference ID (Disease Ontology)
ORDO:342
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:12579009
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0031069
Exact Synonym (Disease Ontology)
benign paroxysmal peritonitis
Exact Synonym (Disease Ontology)
FMF
OrphaNumber from OrphaNet (Orphanet)
342
MeSH unique ID (MeSH (Medical Subject Headings))
D010505